Synonym | 25-Hydroxycalciferol | ||||||||||
Specimen requirement | Adult patient: Clotted blood tube (Serum gel separator clot activator tube) Minimum blood volume: 5 mL |
||||||||||
Paediatric patient: Paediatric clotted blood tube Number of vials: 1 Minimum blood volume: 0.8 mL |
|||||||||||
Authorisation code required | Yes | ||||||||||
24 Hr available service | No | ||||||||||
Precaution |
Blood sample should be collected before starting vitamin D supplement unless there is doubt whether the vitamin is being absorbed. A fasting specimen is recommended. |
||||||||||
Method | Liquid chromatography-tandem mass spectrometry | ||||||||||
Reference interval |
Total 25OH Vitamin D:
(Source: 1. Med J Aust 2012; 196 (11): 686 - 7 2. Med J Aust 2013; 198 (3): 142 - 3) |
||||||||||
Clinical indication | Investigation of
patients with obscure hyper- or hypo-calcaemia. Investigation of suspected rickets and osteomalacia (e.g. malabsorption, dietary deficiency). Investigation of suspected vitamin D toxicity (e.g. hypercalcaemia, nephrocalcinosis, overdose). |
||||||||||
Result interpretation |
Serum total 25-hydroxyvitamin D (25OHD) concentration, mainly the sum of serum 25-hydroxyvitamin D2 and D3 concentrations, is used to evaluate vitamin D status. The biologically active forms of the hormone are 1,25-dihydroxyvitamin Ds which regulate calcium and phosphorous homeostasis. Although 25OHD is usually reliable for the diagnosis of abnormal vitamin D status, in a few instances (e.g. sarcoidosis, oncogenic osteomalacia), 1,25-dihydroxyvitamin D alone is abnormal. |
||||||||||
Measurement of uncertainty | See table. | ||||||||||
Frequency of measurement | 2 weeks |